Issue 5/2020
Content (12 Articles)
Applying Precision to the Management of BRAF-Mutant Metastatic Colorectal Cancer
Benny Johnson, Scott Kopetz
Targeting TAM to Tame Pancreatic Cancer
Mitchell S. von Itzstein, Michael C. Burke, Rolf A. Brekken, Todd A. Aguilera, Herbert J. Zeh, Muhammad Shaalan Beg
Efficacy and Safety of Crizotinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with ROS1 Rearrangement or MET Alteration: A Systematic Review and Meta-Analysis
Huy Gia Vuong, Thu Quynh Nguyen, Hoang Cong Nguyen, Phuoc Truong Nguyen, An Thi Nhat Ho, Lewis Hassell
Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product
Dietger Niederwieser, Caroline Hamm, Patrick Cobb, Mindy Mo, Cecily Forsyth, Alessandra Tucci, Vladimir Hanes, Vincent Delwail, Roman Hajek, David Chien
Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO)
Juan Manuel Sepúlveda-Sánchez, Miguel Gil-Gil, Miriam Alonso-García, María Ángeles Vaz Salgado, Elena Vicente, Carlos Mesía Barroso, Ángel Rodríguez Sánchez, Gema Durán, Ramón De Las Peñas, José Muñoz-Langa, Guillermo Velasco, Aurelio Hernández-Laín, Amaya Hilario, Miguel Navarro Martín, Manuel Benavides, Laura Oleaga, Diana Cantero Montenegro, Yolanda Ruano, Pilar Sánchez-Gómez, María Cruz Martín-Soberón, Robert Morales-Llombart, Vanessa Pachón, Estela Pineda
Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G)
Naoki Izawa, Kohei Shitara, Kimio Yonesaka, Takeharu Yamanaka, Takayuki Yoshino, Yu Sunakawa, Toshiki Masuishi, Tadamichi Denda, Kentaro Yamazaki, Toshikazu Moriwaki, Hiroyuki Okuda, Chihiro Kondoh, Tomohiro Nishina, Akitaka Makiyama, Hideo Baba, Hironori Yamaguchi, Masato Nakamura, Ichinosuke Hyodo, Kei Muro, Takako Eguchi Nakajima
Efficacy, Prognostic Factors, and Safety Profile of Enzalutamide for Non-metastatic and Metastatic Castration-Resistant Prostate Cancer: A Retrospective Single-Center Analysis in Japan
Motohiro Fujiwara, Takeshi Yuasa, Yoshinobu Komai, Noboru Numao, Shinya Yamamoto, Iwao Fukui, Junji Yonese
Small Molecule Destabilizer of β-Catenin and Ras Proteins Antagonizes Growth of K-Ras Mutation-Driven Colorectal Cancers Resistant to EGFR Inhibitors
Jung Kyu Choi, Heeyeong Cho, Byoung-San Moon
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features
Ignazia Tusa, Giulia Cheloni, Martina Poteti, Angela Silvano, Alessandro Tubita, Zoe Lombardi, Antonella Gozzini, Roberto Caporale, Barbara Scappini, Persio Dello Sbarba, Elisabetta Rovida
Sarcopenia in Metastatic Renal Cell Carcinoma Patients Treated with Cabozantinib
Tomas Buchler, Marie Kopecka, Anezka Zemankova, Markéta Wiesnerová, Eva Streckova, Aneta Rozsypalova, Bohuslav Melichar, Alexandr Poprach, Igor Richter
Gilteritinib: A Review in Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukaemia
Connie Kang, Hannah A. Blair
Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis
Roberto Iacovelli, Chiara Ciccarese, Gaetano Facchini, Michele Milella, Federica Urbano, Umberto Basso, Ugo De Giorgi, Roberto Sabbatini, Daniele Santini, Rossana Berardi, Matteo Santoni, Sergio Bracarda, Francesco Massari, Cristina Masini, Michele De Tursi, Riccardo Ricotta, Sebastiano Buti, Fable Zustovich, Pierangela Sepe, Sabrina Rossetti, Marco Maruzzo, Enrico Cortesi, Giampaolo Tortora, Giuseppe Procopio